Compare GHRS & NBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GHRS | NBN |
|---|---|---|
| Founded | 2018 | 1872 |
| Country | Ireland | United States |
| Employees | N/A | 234 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 947.2M | 1.1B |
| IPO Year | 2021 | N/A |
| Metric | GHRS | NBN |
|---|---|---|
| Price | $21.47 | $121.80 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 2 |
| Target Price | $41.38 | ★ $130.50 |
| AVG Volume (30 Days) | ★ 255.6K | 84.8K |
| Earning Date | 05-01-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 0.03% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $13.77 |
| Revenue Next Year | N/A | $18.72 |
| P/E Ratio | ★ N/A | $11.29 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.52 | $79.26 |
| 52 Week High | $24.66 | $135.62 |
| Indicator | GHRS | NBN |
|---|---|---|
| Relative Strength Index (RSI) | 61.88 | 49.82 |
| Support Level | $12.29 | $117.88 |
| Resistance Level | $24.66 | $124.95 |
| Average True Range (ATR) | 1.26 | 4.63 |
| MACD | -0.02 | -0.58 |
| Stochastic Oscillator | 67.11 | 17.59 |
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
Northeast Bank provides banking and financial services to individual and corporate customers in the United States. The firm conducts its loan-related activities through two primary channels: the Community Banking Division, and the Small Business Administration (SBA) National Division. Its loan portfolio comprises residential mortgage loans; multi-family and other commercial real estate loans; commercial and industrial loans, consumer loans, and small business administration loans. The firm also provides telephone banking, online banking, mobile banking, and remote deposit capture services. The revenue of the company is derived principally from interest and dividends from the bank.